Warning Letter Roundup & Recap – Feb. 14, 2017
Executive Summary
Refusing a US FDA inspection brought a warning letter to a Chinese maker of surgical gear; quality systems violations noted at a blood glucose test meter company; a California-based marketer of diagnostic equipment marketed an unapproved device. FDA issued three device-related warning letters the week of Feb. 14.